Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
O
Theofilogiannakos, E. K., Theofilogiannakos G. K., Anogeianaki A., Yioultsis T. V., Danias P. G., Stergiou-Michailidou V., et al. (2009).  One heart, two bodies: a simulation study of body surface potential differences between donor and recipient of heart transplantation.. Stud Health Technol Inform. 142, 389-91.
Tagarakis, G. I., Voucharas C., Tsolaki F., Daskalopoulos M. E., Papaliagkas V., Parisis C., et al. (2012).  Ondasetron versus haloperidol for the treatment of postcardiotomy delirium: a prospective, randomized, double-blinded study.. J Cardiothorac Surg. 7, 25.
Imprialos, K. P., Stavropoulos K., & Doumas M. (2017).  Once-Weekly Exenatide and Cardiovascular Outcomes in Type 2 Diabetes.. N Engl J Med. 377(25), 2502.
Stoimenis, D., Karagiannis T., Katsoula A., Athanasiadou E., Kazakos K., Bekiari E., et al. (2017).  Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis.. Expert Opin Pharmacother. 18(9), 843-851.
Stoimenis, D., Karagiannis T., Katsoula A., Athanasiadou E., Kazakos K., Bekiari E., et al. (2017).  Once-weekly dipeptidyl peptidase-4 inhibitors for type 2 diabetes: a systematic review and meta-analysis. Expert Opinion on Pharmacotherapy. 18555857646565(9111111), 843 - 851.
Tamburro, F. R., Castellan P., Neri F., Berardinelli F., Bada M., Sountoulides P., et al. (2018).  Onabotulinumtoxin-A improves health status and urinary symptoms in subjects with refractory overactive bladder: Real-life experience.. Urologia. 85(4), 163-168.
Rizos, E. C., Markozannes G., Tsapas A., Mantzoros C. S., & Ntzani E. E. (2021).  Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis.. Heart. 107(2), 150-158.
Tziomalos, K., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2008).  Omega-3 fatty acids: how can they be used in secondary prevention?. Curr Atheroscler Rep. 10(6), 510-7.
Malamas, A., Chranioti A., Tsakalidis C., Dimitrakos S. A., & Mataftsi A. (2017).  The omega-3 and retinopathy of prematurity relationship.. Int J Ophthalmol. 10(2), 300-305.
Pitsiladis, Y. P., Abatzis-Papadopoulos M., Ali N., Aggeloudis S., Atkinson C., Constandache B., et al. (2019).  The Olympia Declaration.. Curr Sports Med Rep. 18(12), 448-451.
Shimizu, S., Saito M., Oiwa H., Ohmasa F., Tsounapi P., Oikawa R., et al. (2014).  Olmesartan ameliorates urinary dysfunction in the spontaneously hypertensive rat via recovering bladder blood flow and decreasing oxidative stress.. Neurourol Urodyn. 33(3), 350-7.
Botsoglou, E., Govaris A., Fletouris D., & Iliadis S. (2013).  Olive leaves (Olea europea L.) and α-tocopheryl acetate as feed antioxidants for improving the oxidative stability of α-linolenic acid-enriched eggs.. J Anim Physiol Anim Nutr (Berl). 97(4), 740-53.
Goulas, A., Triplett E. L., & Taborsky G. (1996).  Oligophosphopeptides of varied structural complexity derived from the egg phosphoprotein, phosvitin.. J Protein Chem. 15(1), 1-9.
Katsikis, I., Mouslech T., Kourtis A., Panidis D., & Georgopoulos N. A. (2009).  Oligo-ovulation or anovulation and hyperandrogenemia contribute to the decreased serum adiponectin levels in normal-weight women with PCOS with obesity and insulin resistance.. Fertil Steril. 91(4), e3; author reply e4.
Tsakiropoulou, E., Konstantinidis I., Chatziavramidis A., & Constantinidis J. (2013).  Olfactory dysfunction as first presenting symptom of cranial fibrous dysplasia.. BMJ Case Rep. 2013,
Metallidis, S., Tsachouridou O., Skoura L., Zebekakis P., Chrysanthidis T., Pilalas D., et al. (2013).  Older HIV-infected patients--an underestimated population in northern Greece: epidemiology, risk of disease progression and death.. Int J Infect Dis. 17(10), e883-91.
Demirtzoglou, G., Chrysoglou S-I., Katopodi T., Dimitroulas T., Iakovidou-Kritsi Z., Garyfallos A., et al. (2023).  Olanzapine's Cytogenetic Effect on T Lymphocytes in Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients: In Vitro Study.. Cureus. 15(4), e37683.
Constantinos, Z., Eleni P., Goulas A., & Iakovidou-Kritsi Z. (2015).  Olanzapine: evaluation of the in vivo cytogenetic effect.. Hum Psychopharmacol. 30(3), 189-92.
Augood, C., Chakravarthy U., Young I., Vioque J., de Jong P. T. V. M., Bentham G., et al. (2008).  Oily fish consumption, dietary docosahexaenoic acid and eicosapentaenoic acid intakes, and associations with neovascular age-related macular degeneration.. Am J Clin Nutr. 88(2), 398-406.
Polyzos, S. A., Makras P., Tournis S., & Anastasilakis A. D. (2019).  Off-label uses of denosumab in metabolic bone diseases.. Bone. 129, 115048.
Athyros, V. G., Katsiki N., & Karagiannis A. (2016).  Off target effects of statins shape total mortality?. J Drug Assess. 5(1), 4-5.
Hauser, S. L., Bar-Or A., Cohen J. A., Comi G., Correale J., Coyle P. K., et al. (2020).  Ofatumumab versus Teriflunomide in Multiple Sclerosis.. N Engl J Med. 383(6), 546-557.
Boutari, C., Polyzos S. A., & Mantzoros C. S. (2019).  Of mice and men: Why progress in the pharmacological management of obesity is slower than anticipated and what could be done about it?. Metabolism. 96, vi-xi.
Karkos, P. D. (2003).  Oesophagopharyngeal reflux.. Br J Gen Pract. 53(494), 674-5.
Sachinis, N. P., Sinopidis C., Baliaka A., & Givissis P. (2015).  Odyssey of an elbow synovial chondromatosis.. Orthopedics. 38(1), e62-7.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.